Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins
Mohamed Mahdi-Rogers, Yusuf A RajaballyNeuromuscular Clinic, Department of Neurology, University Hospitals of Leicester, Leicester, UKAbstract: Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired heterogeneous disorder of immune origin affecting the peripheral nerves, causing mot...
Guardado en:
Autores principales: | Mohamed Mahdi-Rogers, Yusuf A Rajabally |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/08703592792a447f8986ca98481a8ebf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy
por: Rajabally YA, et al.
Publicado: (2020) -
Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy
por: Michael A. Tortorici, et al.
Publicado: (2021) -
Corneal inflammatory cell infiltration predicts disease activity in chronic inflammatory demyelinating polyneuropathy
por: Jeremias Motte, et al.
Publicado: (2021) -
The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes--an observational study.
por: Samantha K Dunnigan, et al.
Publicado: (2014) -
THE ROLE OF INTERLEUKIN 1β GENE POLYMORPHISM IN DEVELOPMENT OF PREDOMINANTY SENSORY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
por: T. E. Popova, et al.
Publicado: (2019)